Literature DB >> 29209709

Treating Specific Variants Causing Cystic Fibrosis.

Garry R Cutting1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29209709     DOI: 10.1001/jama.2017.16823

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  4 in total

1.  A Proteomic Variant Approach (ProVarA) for Personalized Medicine of Inherited and Somatic Disease.

Authors:  Darren M Hutt; Salvatore Loguercio; Alexandre Rosa Campos; William E Balch
Journal:  J Mol Biol       Date:  2018-06-18       Impact factor: 5.469

2.  Residual function of cystic fibrosis mutants predicts response to small molecule CFTR modulators.

Authors:  Sangwoo T Han; Andras Rab; Matthew J Pellicore; Emily F Davis; Allison F McCague; Taylor A Evans; Anya T Joynt; Zhongzhou Lu; Zhiwei Cai; Karen S Raraigh; Jeong S Hong; David N Sheppard; Eric J Sorscher; Garry R Cutting
Journal:  JCI Insight       Date:  2018-07-26

3.  DNAJB12 and Hsp70 triage arrested intermediates of N1303K-CFTR for endoplasmic reticulum-associated autophagy.

Authors:  Lihua He; Andrew S Kennedy; Scott Houck; Andrei Aleksandrov; Nancy L Quinney; Alexandra Cyr-Scully; Deborah M Cholon; Martina Gentzsch; Scott H Randell; Hong Yu Ren; Douglas M Cyr
Journal:  Mol Biol Cell       Date:  2021-02-03       Impact factor: 4.138

4.  Capitalizing on the heterogeneous effects of CFTR nonsense and frameshift variants to inform therapeutic strategy for cystic fibrosis.

Authors:  Neeraj Sharma; Taylor A Evans; Matthew J Pellicore; Emily Davis; Melis A Aksit; Allison F McCague; Anya T Joynt; Zhongzhu Lu; Sangwoo T Han; Arianna F Anzmann; Anh-Thu N Lam; Abigail Thaxton; Natalie West; Christian Merlo; Laura B Gottschalk; Karen S Raraigh; Patrick R Sosnay; Calvin U Cotton; Garry R Cutting
Journal:  PLoS Genet       Date:  2018-11-16       Impact factor: 5.917

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.